Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/34147
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12973]
Metadata
Show full item record
INACTIVATION AND REMOVAL OF CHIKUNGUNYA VIRUS AND MAYARO VIRUS FROM PLASMA-DERIVED MEDICINAL PRODUCTS
Nanofiltração
Inativação
Vírus Chikungunya
Tratamento S / D
Tratamento térmico
Filtragem retentiva de vírus
Mayaro vírus
Medicamentos derivados de plasma
Inactivation
Heat treatment
S/D treatment
Chikungunya virus
Mayaro virus
Virus retentive filtration
Nanofiltration
Plasma-derived medicinal products
Author
Affilliation
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Asahi Kasei. Cologne, Germany.
Asahi Kasei. Cologne, Germany.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Asahi Kasei. Cologne, Germany.
Asahi Kasei. Cologne, Germany.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Paul-Ehrlich-Institut. Department of Virology. Langen, Germany.
Abstract
Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are closely related members of the Semliki Forest complex within the genus alphavirus and are transmitted by arthropods, causing acute febrile illness in humans. CHIKV has spread to almost all continents, whereas autochthonous MAYV infections have been reported in South America and in the Caribbean. Nevertheless, there was concern about potential spread of MAYV to other regions similar to CHIKV in the past. The risk for transmission of emerging viruses by blood transfusion and the safety of plasma-derived medicinal products (PDMPs) are constant concerns. The manufacturing processes of PDMPs include procedures to inactivate/remove viruses.
Keywords in Portuguese
AlphavirusNanofiltração
Inativação
Vírus Chikungunya
Tratamento S / D
Tratamento térmico
Filtragem retentiva de vírus
Mayaro vírus
Medicamentos derivados de plasma
Keywords
AlphavirusesInactivation
Heat treatment
S/D treatment
Chikungunya virus
Mayaro virus
Virus retentive filtration
Nanofiltration
Plasma-derived medicinal products
Share